Skip to content
10-Q

Quarterly Report

Alterola Biotech, Inc.

0001477932-24-007731

← back to feed
Filed
Nov 29, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Nov 15, 2024 1.46B sh
Operating Cash Flow Q2 2025 · Sep 30, 2024 −$1.07M
Operating Cash Flow Q2 2025 · Sep 30, 2023 −$197.63K
Cash And Equivalents Q2 2025 · Sep 30, 2024 $82.72K
Cash And Equivalents Q2 2025 · Mar 31, 2024 $2.65K
Stockholders Equity Q2 2025 · Sep 30, 2024 −$2.05M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$1.33M
Stockholders Equity restated Q2 2025 · Mar 31, 2023 $9.76M
Current Liabilities Q2 2025 · Sep 30, 2024 $3.62M
Current Liabilities Q2 2025 · Mar 31, 2024 $1.33M
Total Liabilities Q2 2025 · Sep 30, 2024 $3.62M
Total Liabilities Q2 2025 · Mar 31, 2024 $1.33M
Total Liabilities Q2 2025 · May 28, 2021 $389.72K
Current Assets Q2 2025 · Sep 30, 2024 $1.15M
Current Assets Q2 2025 · Mar 31, 2024 $3.66K
Total Assets Q2 2025 · Sep 30, 2024 $1.36M
Total Assets Q2 2025 · Mar 31, 2024 $3.66K
Sga Expense Q2 2025 · Sep 30, 2024 $24.02K
Sga Expense Q2 2025 · Sep 30, 2024 $67.48K
Sga Expense Q2 2025 · Sep 30, 2023 $23.64K
Sga Expense Q2 2025 · Sep 30, 2023 $25.4K
Rd Expense Q2 2025 · Sep 30, 2024 $16.96K
Rd Expense Q2 2025 · Sep 30, 2024 $36.1K
Rd Expense Q2 2025 · Sep 30, 2023 $0
Rd Expense Q2 2025 · Sep 30, 2023 $0
Net Income Q2 2025 · Sep 30, 2024 −$799.19K
Net Income Q2 2025 · Sep 30, 2024 −$1.45M
Net Income restated Q2 2025 · Sep 30, 2023 −$123.16K
Net Income Q2 2025 · Sep 30, 2023 −$854.89K
Operating Income Q2 2025 · Sep 30, 2024 −$477.23K
Operating Income Q2 2025 · Sep 30, 2024 −$1.16M
Operating Income restated Q2 2025 · Sep 30, 2023 −$123.16K
Operating Income Q2 2025 · Sep 30, 2023 −$716.72K
Revenue Q2 2025 · Sep 30, 2024 $0
Revenue Q2 2025 · Sep 30, 2024 $0
Revenue Q2 2025 · Sep 30, 2023 $0
Revenue Q2 2025 · Sep 30, 2023 $0